Remove Article Remove Pharmaceuticals Remove Psychedelic therapy
article thumbnail

One Person’s Journey from Celebrity Medical Model Advocate to Skeptic: An Interview with Rose Cartwright

Mad in America

You write that you worry about how psychedelics are getting co-opted by pharmaceutical industries. Cartwright: I do an exercise in my book where I speculate that if psychedelic therapy been available to my mother when she was at her worst, would it have been helpful? Dhar: That was my favorite part, the gentleness.

article thumbnail

A Win for Science, with Profound Implications for Industry: FDA Rejects MDMA

Mad in America

L ykos Therapeutics experienced a double blow this week, with the FDA’s rejection of their proprietary MDMA-assisted therapy for PTSD and the retraction of three articles on MDMA’s supposed efficacy. Moreover, Lykos is a small company bringing it to market, one that emerged out of a psychedelic research nonprofit (MAPS).